Biophysical Society 59th Annual Meeting Program Guide

Name

Disclosure Entity

Disclosure Type

Presentation Number

Large, Charles Law, Richard

Autifony Therapeutics Limited Employment (full or part-time) in funding company 635-Pos

Evotec (U.K.) Ltd.

Employment (full or part-time) in funding company 1791-Plat

Lazar, Josef

Innovative Bioimaging, LLC Stock options or bond holdings in a for-profit corpo- ration or self-directed pension plan

1643-Pos

Lee, Jo Li, Jiali

UCB Pharma NIHGrant

Research funded by industry grant

1548-Pos 874-Pos 635-Pos

Other

Liang, Qiansheng

Autifony Therapeutics Limited Research funded by industry grant

Liao, Jinfang Lin, Kun-Han

AAT Bioquest

Employment (full or part-time) in funding company 549-Pos

Cytocentrics Bioscience GmbH Employment (full or part-time) in funding company 2954-Pos

Liu, Zhiqi

ChanTest

Employment (full or part-time) in funding company 2955-Pos

Livesay, Dennis Louttit, James

MedImmune Ltd GlaxoSmithKline

Research funded by industry grant

1893-Pos

Employment (full or part-time) in funding company 605-Pos

Ludescher, Richard

Pepsi Co.

Research funded by industry grant

3139-Pos 1346-Pos

Ma, Jianjie

Founder of Trim-edicine

Other

Mangan, Kile Mayer, Michael Mayer, Michael

CDI

Employment (full or part-time) in funding company 2968-Pos

Oxford Nanopore

Research funded by industry grant Research funded by industry grant

872-Pos 876-Pos

Oxford Nanopores Technologies Ltd

McKay, Craig

Molecular Devices, LLC

Employment (full or part-time) in funding company 1434-Pos Employment (full or part-time) in funding company 2968-Pos

McLachlan, Michael McNabb, David Meline, Benjamin Meline, Benjamin

CDI

NIHGrant

Other

874-Pos

CDI CDI

Employment (full or part-time) in funding company 3014-Pos Employment (full or part-time) in funding company 2968-Pos Employment (full or part-time) in funding company 810-Pos

Mellman, Ira

Genentech, Incorporated, a member of the Roche Group

Melosh, Nicholas

Stealth Biosciences

Stock options or bond holdings in a for-profit corpo- ration or self-directed pension plan Stock options or bond holdings in a for-profit corpo- ration or self-directed pension plan

743-Pos

Melosh, Nicholas

Stealth Biosciences

2876-Pos

Meyer, Nathan Mirams, Gary

CDI

Ownership or Partnership in funding organization 2968-Pos

GlaxoSmithKline

Research funded by industry grant

605-Pos

Miu, Peter

Molecular Devices, LLC

Employment (full or part-time) in funding company 1434-Pos Consulting fees or other remuneration from industry 663-Pos

Moss, Richard

Consultant for Myokardia, Inc.

Nandivada, Santoshi

NIHGrant Berg LLC

Other

874-Pos

Narain, Niven Nelson, Philip

Ownership or Partnership in funding organization 1243-Pos

WH Freeman and Co.

Receipt of royalties from referenced company products

1673-Pos

Obejero-Paz, Carlos Ozcan, Aydogan

ChanTest Corporation

Employment (full or part-time) in funding company 2945-Pos

Holomic LLC

Non-remunerative positions of influence such as officer, board member, trustee, or public spokesper- son in company Receipt of royalties from referenced company products Stock options or bond holdings in a for-profit corpo- ration or self-directed pension plan

1861-Wkshp

Peterman, Erwin

LUMICKS

2557-Plat

Peterman, Erwin

LUMICKS

832-Pos

Peterson, Raymond

Celadon Laboratories

Employment (full or part-time) in funding company 1985-Pos

254

Biophysical Society 59 th Annual Meeting, Baltimore, Maryland

Made with